New! Sign up for our free email newsletter.
Science News
from research organizations

Brain peptide research may lead to promising new treatments for mental illnesses

Date:
September 7, 2016
Source:
Wiley
Summary:
Recent research points to the importance of a molecule called relaxin-3 in the brain, with effects on various processes and behaviors such as mood, stress, and cognition. Because these are often aberrant in mental illnesses, investigators are studying the potential of relaxin-3-based interventions to treat depression, anxiety, and other conditions.
Share:
FULL STORY

Recent research points to the importance of a molecule called relaxin-3 in the brain, with effects on various processes and behaviors such as mood, stress, and cognition. Because these are often aberrant in mental illnesses, investigators are studying the potential of relaxin-3-based interventions to treat depression, anxiety, and other conditions.

A new review looks at where such research stands and what additional studies are necessary.

"There is a need for new and better drugs for mental illnesses. An accumulation of recent research points to potential that relaxin-3 and its receptor RXFP3 may be a new target for treatment of these disorders," said Dr. Gavin Dawe, senior author of the British Journal of Pharmacology review.

"Developments in stapled peptide technology -- whereby peptides are chemically stabilized by crosslinking with small molecules -- are now opening prospects for selectively targeting RXFP3 to develop a new class of drugs for mental illnesses."


Story Source:

Materials provided by Wiley. Note: Content may be edited for style and length.


Journal Reference:

  1. Jigna Rajesh Kumar, Ramamoorthy Rajkumar, Tharindunee Jayakody, Subhi Marwari, Jia Mei Hong, Sherie Ma, Andrew L Gundlach, Mitchell K P Lai, Gavin S Dawe. Relaxin’ the brain: a case for targeting the nucleus incertus network and relaxin-3/RXFP3 system in neuropsychiatric disorders. British Journal of Pharmacology, 2016; DOI: 10.1111/bph.13564

Cite This Page:

Wiley. "Brain peptide research may lead to promising new treatments for mental illnesses." ScienceDaily. ScienceDaily, 7 September 2016. <www.sciencedaily.com/releases/2016/09/160907113356.htm>.
Wiley. (2016, September 7). Brain peptide research may lead to promising new treatments for mental illnesses. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2016/09/160907113356.htm
Wiley. "Brain peptide research may lead to promising new treatments for mental illnesses." ScienceDaily. www.sciencedaily.com/releases/2016/09/160907113356.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES